A Blockbuster Drug
Lyrica truly merits the description ‘blockbuster drug’. FDA approved for seizures, neuropathic pain, fibromyalgia (2007), and generalized anxiety disorder (Europe), Lyrica (pregabalin) sales hit their peak in the last quarter in the US, bringing in over $550 million for Pfizer.
Lyrica’s Read more [...]
Researchers used a broad brush when they focused on the most easily understood aspect of the disorder - fatigue. Now, in this bold and provocative blog, the first part of a four-part series called "A Neuroinflammatory Model of ME/CFS", guest blogger Marco proposes that other symptoms, none Read more [...]